description

The malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to increased risk of death in hospitalized COVID-19 patients, according to a large study published in the medical journal Lancet. Conway G. Gittens has the study's finding.

general info

  • Uploaded    05/22/2020
  • Business & Finance
  • Vaccines more relevant than China for investors: CIO
  • Stocks end mostly higher on Trump China comments
  • Fed's Powell to unemployed: We're here for you
  • UK helps employers with slow phase-in of job shield costs
  • Renault closes site, restructures in bid to slash costs
  • First successful flight for world's largest all-electric plane
  • 197 cars: all the UK could produce in April
  • IPO values coffee maker JDE Peet's at $17.3bln
  • Canopy Growth shares plummet